- Home
- RYAM vs BNTC Comparison
RYAM vs BNTC Comparison
Compare RYAM & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYAM
- BNTC
- Stock Information
- Founded
- RYAM 1926
- BNTC 1995
- Country
- RYAM United States
- BNTC United States
- Employees
- RYAM N/A
- BNTC 16
- Industry
- RYAM Paper
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- RYAM Basic Materials
- BNTC Health Care
- Exchange
- RYAM Nasdaq
- BNTC Nasdaq
- Market Cap
- RYAM 312.4M
- BNTC 322.6M
- IPO Year
- RYAM N/A
- BNTC N/A
- Fundamental
- Price
- RYAM $4.40
- BNTC $13.75
- Analyst Decision
- RYAM Buy
- BNTC Strong Buy
- Analyst Count
- RYAM 1
- BNTC 7
- Target Price
- RYAM $11.00
- BNTC $24.71
- AVG Volume (30 Days)
- RYAM 628.5K
- BNTC 64.1K
- Earning Date
- RYAM 05-06-2025
- BNTC 05-12-2025
- Dividend Yield
- RYAM N/A
- BNTC N/A
- EPS Growth
- RYAM N/A
- BNTC N/A
- EPS
- RYAM N/A
- BNTC N/A
- Revenue
- RYAM $1,630,308,000.00
- BNTC N/A
- Revenue This Year
- RYAM $1.51
- BNTC N/A
- Revenue Next Year
- RYAM $4.47
- BNTC N/A
- P/E Ratio
- RYAM N/A
- BNTC N/A
- Revenue Growth
- RYAM N/A
- BNTC N/A
- 52 Week Low
- RYAM $3.72
- BNTC $5.08
- 52 Week High
- RYAM $10.28
- BNTC $16.90
- Technical
- Relative Strength Index (RSI)
- RYAM 26.48
- BNTC 55.16
- Support Level
- RYAM $4.54
- BNTC $13.26
- Resistance Level
- RYAM $5.25
- BNTC $14.22
- Average True Range (ATR)
- RYAM 0.33
- BNTC 1.37
- MACD
- RYAM -0.02
- BNTC 0.08
- Stochastic Oscillator
- RYAM 3.82
- BNTC 87.27
About RYAM Rayonier Advanced Materials Inc.
Rayonier Advanced Materials Inc is engaged in the production of cellulose specialties, a natural polymer used in the manufacturing of various specialty chemical products, including liquid crystal displays, filters, textiles and performance additives for pharmaceutical, food and other industrial applications. The company's products are used in a variety of applications, including cigarette filters, liquid crystal displays, paints, pharmaceuticals, and food. The company operates in the reportable segments of High Purity Cellulose, Paperboard, and High-Yield Pulp. The key revenue is derived from the High Purity Cellulose segment. Geographically, it derives a majority of its revenue from the United States.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.